$BLRX· SEC filing ·

BLRX and Hemispherian Report GLIX1 Preclinical Data Showing Potent Anti-Tumor Effect in Glioblastoma Models

BioLineRX Ltd · Now $3.78

+44% in 7d after detection

Post-detection moves

1h
1d
+4.6%
3d
+16%
7d
+44%
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS